核素心肌显像测定MBF和CFR在冠心病的诊断价值及展望  

Diagnostic value and prospect of MBF and CFR measured by radionuclide myocardial imaging in coronary heart disease

作　　者：韩梦月 谢锋[1] 朱芳[1] 吴天慧 兹金萍 周津卉 陈柏青 王文佳 HAN Mengyue;XIE Feng;ZHU Fang;WU Tianhui;ZI Jinping;ZHOU Jinhui;CHEN Baiqing;WANG Wenjia(Nuclear Medicine Department,People s Hospital of Liaoning Provincial,Shenyang,Liaoning 110000,China)

机构地区：[1]辽宁省人民医院核医学科,辽宁省沈阳市110000

出　　处：《中国动脉硬化杂志》2022年第3期260-264,共5页Chinese Journal of Arteriosclerosis

基　　金：辽宁省自然科学基金项目(20180530109)。

摘　　要：心血管疾病是世界范围内最主要的死亡原因,其治疗和诊断的经济成本很高,在过去的20年里,对冠心病患者诊断、评估及治疗越来越准确和有效。正电子发射断层显像技术是一种强大而多功能的无创性影像学检查,特别是通过量化心肌血流量(MBF)及冠状动脉血流储备(CFR)可以更好地描述冠状动脉疾病的特征,在冠状动脉微血管病变及缺血性心肌病的早期诊断、分级及治疗中发挥着重大作用。Cardiovascular disease is the leading cause of death in the world.The economic cost of treatment and diagnosis is very high.In the past two decades,the diagnosis,treatment and evaluation of patients with coronary heart disease have undergone various changes.Positron emission tomography is a powerful and multi-functional noninvasive imaging examination,especially by quantifying the myocardial blood flow and coronary flow reserve,it can better describe the characteristics of coronary artery disease,play an important role in the early diagnosis,classification and treatment of coronary microvascular disease and ischemic cardiomyopathy.

关 键 词：正电子发射断层显像技术 心肌灌注显像 心肌血流量 冠状动脉血流储备 冠状动脉微血管病变 

分 类 号：R5[医药卫生—内科学]